BCAL Diagnostics Health Care
Cancer Healthcare Medical

$0.070 (0%)

High $0.08	Low $0.07	Trades 14	Turnover $24,276	Volume 333,655
30 June 2023 at 4:10pm

Market Cap (3-Aug) $24,701,782 (1,550th)	Close (30-Jun) $0.070 0 (0%)	Volume (30-Jun) 333,655	Shortsold (6-Jun) 304 (0.00%) (624th)
52w High $0.155	52w Low $0.052	P/E -	EPS -0.02

Short Interest

ASIC data, 6 Jun 2025

% Shorted

0.00%

vs 0.00% prior report

Most Shorted Rank

624th

of 710 shorted ASX stocks

Peak Short

0.36%

Jul 2021

Days to Cover

0.0

at 50d avg vol

View full short position history →

	Subject
	BDX BDX Ann: Strong Cohort 4 Testing Data Demonstrates Value of BCAL Test
	1 (current) 2 3
	BDX BDX Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	BDX BDX Ann: Ceasing to be a substantial holder
	BDX BDX Ann: letter to Shareholders AGM Notice
	BDX BDX Ann: Notice of Annual General Meeting/Proxy Form
	BDX BDX Ann: AGM Date and Closing Date for Director Nominations
	BDX BDX Ann: Appendix 4G and Corporate Governance Statement
	BDX BDX Ann: Annual Report to shareholders
	BDX BDX Ann: Change of Director's Interest Notice
	BDX BDX Ann: Change of Director's Interest Notice
	BDX BDX Ann: Australian Clinical Studies Launched
	BDX BDX Ann: Preliminary Final Report
	BDX BDX Ann: Market Update
	BDX BDX Ann: Becoming a substantial holder
	BDX BDX Ann: BCAL Diagnostics to List on ASX After Raising $10m in IPO
	BDX BDX Ann: BCAL Diagnostics Investor Presentation
	BDX BDX Ann: Initial Directors Interest Notice X 5
	BDX BDX Ann: Initial Substantial Shareholder Notice X 4
	BDX BDX Ann: Pre-Quotation Disclosure
	BDX BDX Ann: Top 20 Holders
	BDX BDX Ann: Distribution Schedule
	BDX BDX Ann: Securities Trading Policy
	BDX BDX Ann: Equity Incentive Plan Rules
	BDX BDX Ann: Terms & Conditions of Options
	BDX BDX Ann: Interim Report 31 December 2020
	BDX BDX Ann: Annual Report 30 June 2020
	BDX BDX Ann: Annual Report 30 June 2019
	BDX BDX Ann: Constitution
	BDX BDX Ann: Prospectus
	BDX BDX Ann: Appendix 1A and Information Form and Checklist
	BDX BDX Ann: ASX Market Release - Admission and Quotation
	BDX BDX Article: Cancer testing biz BCAL launches IPO; targets July listing

End of Day Prices

Date	Close	Volume	Change
03-Aug	$0.07	80,486	0.00 (0.00%)
31-Jul	$0.07	219,348	0.00 (4.29%)
30-Jul	$0.07	198,646	0.00 (4.11%)
29-Jul	$0.07	119,285	+0.00 (2.82%)
28-Jul	$0.07	8,078	0.00 (0.00%)
27-Jul	$0.07	7,853	-0.01 (8.97%)
24-Jul	$0.08	1,888	+0.00 (4.00%)
23-Jul	$0.08	51,211	+0.00 (2.74%)
22-Jul	$0.07	37,320	+0.00 (2.82%)
21-Jul	$0.07	90,807	0.00 (5.33%)
20-Jul	$0.08	50,000	0.00 (5.06%)
17-Jul	$0.08	84,223	+0.01 (14.49%)
18-Sep	$0.07	580,702	+0.01 (15.00%)
12-Sep	$0.06	1	0.00 (4.76%)
11-Sep	$0.06	70,290	+0.01 (12.50%)
7 up, 6 down, and 2 flat days

BCAL Diagnostics Health Care
Cancer Healthcare Medical

Short Interest

Followers

Prices

Announcements

End of Day Prices

BDX BCAL Diagnostics Health Care Cancer Healthcare Medical

Short Interest

Followers

Prices

Announcements

End of Day Prices

BCAL Diagnostics Health Care
Cancer Healthcare Medical